Are you Dr. Pardanani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Animesh Pardanani, MD is an oncologist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Wisconsin, and South Dakota. He is affiliated with Mayo Clinic Hospital - Rochester and is an Assistant Professor at Mayo Medical School.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2003
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1997 - 2000- Mayo Clinic College of MedicineClass of 1992
Certifications & Licensure
MN State Medical License 2000 - 2026
SD State Medical License Active through 2025
WI State Medical License 2024 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) Start of enrollment: 2009 Nov 01
- Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome Start of enrollment: 2011 May 01
- Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
American Journal of Hematology. 2024-12-13 - 1 citationsPHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, Fnu Aperna, Anuya Natu
American Journal of Hematology. 2024-12-01 - When and how to transplant in myelofibrosis - recent trends.Naman Sharma, Giuseppe G Loscocco, Naseema Gangat, Paola Guglielmelli, Animesh Pardanani
Leukemia & Lymphoma. 2024-11-14
